Navegação Ciências da Saúde por Assunto "Type 2 deiodinase"

Resultados 1-2 de 2

    • Liraglutide activates type 2 deiodinase and enhances β3-adrenergic-induced thermogenesis in mouse adipose tissue 

      Oliveira, Fernanda Cerqueira Barroso de; Bauer, Eduarda Jacinto; Ribeiro, Carolina Martins; Pereira, Sidney Alcântara; Beserra, Bruna T. S.; Wajner, Simone Magagnin; Maia, Ana Luiza Silva; Neves, Francisco de Assis Rocha; Coelho, Michella S.; Amato, Angélica Amorim (2022) [Artigo de periódico]
      Aims: Liraglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist used as an anti-hyperglycemic agent in type 2 diabetes treatment and recently approved for obesity management. Weight loss is attributed ...

    • Type 2 deiodinase Thr92Ala polymorphism is not associated with cognitive impairment in older adults : a cross-sectional study 

      Schwengber, Wallace Klein; Silveira, Vítor Böck; Hetzel, Guilherme Moreira; Robaina, Amanda; Ceolin, Lucieli; Camelier, Marli Teresinha Viapiana; Goemann, Iuri Martin; Dalla Corte, Roberta Rigo; Scheffel, Rafael Selbach; Mello, Renato Gorga Bandeira de; Maia, Ana Luiza Silva; Dora, José Miguel Silva (2022) [Artigo de periódico]
      Background: Type 2 Deiodinase (DIO2) converts thyroxine (T4) into the active hormone triiodothyronine (T3). Thr92Ala DIO2 polymorphism has been associated with reduced conversion of T4 into T3 and central nervous system ...